Productive AI helps scientists design entirely new RNA-transfering proteins.
Recently, there have been several recent developments in the field of international medical health, and these developments continue to attract the attention of the industry and the public. Researchers at the Universities of Helmut Zlinska and the University of Toulouse have developed a completely new class of RNA transporters (STVs). To this end, they use generative AI to design naturally occurring protein building blocks and synthesized proteins.
Systematic screening identifies STV-C8 as the most effective candidate: in cell culture, it carries RNA more efficiently than the lipid nanoparticles (NP) tested, and can be adapted to different RNA carriers and cell membranes. In animal models, the team confirmed that the system can also play a role in living organisms. RNA-based drugs use RNA as a blueprint to enable cells to produce specific proteins, including those that can accurately alter genes.
To achieve this, RNA must reach the cell's interior completely intact. Currently, delivery systems for this purpose include virus-driven vehicles and lipid nanoparticles, which are composed of fatty molecules. Both methods are limited.
Researchers are therefore studying new mechanisms that can more efficiently import RNA into cells, and in the future, they may be more selective to import RNA into cells. Researchers at the Universities of Industry and Munich, such as the Hermannheim Institute of Technology and the Munich Institute of Technology, have now built an RNA transporter from the ground up. The team combines functional protein-building blocks with structural protein design using AI-generated structures to design efficient RNA transport for specific tasks.
The research team's lead researcher, Dr. Christoph Gruber, is the head of the ISF team and the first author of the study. The team tested more than 100 variants.
It is surprising that it works particularly well with proteins with an unnatural geometric shape structure. STV-C8 is the most effective. Postdoctoral researcher, Dr.
Fred Mark Christ Schmick, ISF Institute and first author, explains the key findings and authorship of the study. It shows the potential of using AI systems to design protein space. (In cell culture, STV-C8 delivered RNA into target cells far more efficiently than the virus-like particles and lipid nanoparticles tested.
to achieve comparable protein production, STV-C8 required substantiall. It should be noted that the above content is based on international public research findings and is for reference in HealthCop and does not constitute a clinical recommendation.
